MedCity News October 21, 2020
The disruption to biopharma and medtech businesses caused by Covid-19, such as product launch and clinical trial delays, has underscored the need for a more digital focused strategy.
The public health crisis of Covid-19 continues to cast a long shadow on business operations everywhere, including the biopharma industry. It is preventing sales reps from visiting doctors, delaying product launches and making them more complex to execute. It is also impacting clinical trials and underscoring the need for a more digital focused strategy for pharma companies.
Kal Patel, MD, is the CEO and co-founder of BrightInsight, which developed a digital health platform for medical device and biopharma companies. This regulated digital health platform enables companies to host and maintain their regulated...
Today's Sponsors
Today's Sponsor